![Michael Berendt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Berendt
Ordförande på
Anchor Therapeutics, Inc.
Profil
Michael J.
Berendt is currently the Executive Chairman at Anchor Therapeutics, Inc. He previously served as the President & Chief Executive Officer at Aegera Therapeutics, Inc. and as the Group Director-Drug Discovery at Pfizer Inc. He has also served as an Independent Director at Waters Corp.
and as a Director at Onyx Pharmaceuticals, Inc. and Myriad Genetics, Inc. Additionally, he was the Managing Director at AEA Investors LP and RCT BioVentures.
He served as the Director, Chief Executive & Scientific Officer at Telesta Therapeutics, Inc. and as a Director at Northstar Neuroscience, Inc., Catalyst Bioscience, Inc., Trillium Therapeutics, Inc., Alethia Biotherapeutics, Inc., Research Corporation Technologies, Inc., Neomed Institute, and ProMetic Plasma Resources, Inc. He holds a doctorate degree from Drexel University, a graduate degree from Miami University, and an undergraduate degree from Ohio Dominican University.
Aktiva positioner av Michael Berendt
| Företag | Position | Start |
|---|---|---|
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Ordförande | - |
Tidigare kända positioner av Michael Berendt
| Företag | Position | Slut |
|---|---|---|
| WATERS CORPORATION | Direktör/Styrelseledamot | 2021-10-05 |
| TELESTA THERAPEUTICS INC | Verkställande Direktör | 2016-11-01 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Direktör/Styrelseledamot | 2014-06-06 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Verkställande Direktör | 2011-07-01 |
RCT BioVentures
 RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Företagsledare/Principal | 2005-12-01 |
Michael Berendts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
81
Första gradens relationer
20
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 20 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Waters Corp.
 Waters Corp. Medical SpecialtiesHealth Technology Designs, manufactures, sells and services analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
AEA Investors LP
 AEA Investors LP Investment ManagersFinance AEA Investors invests in middle-market companies located across the globe primarily in North America and Europe with an enterprise value of USD 400 million - 2.5 billion and an EBITDA of USD 5 - 200 million. The firm focuses on companies operating in the fields of industrial & industrial services, tech-enabled business services and tech-enabled healthcare services. It participates in buyout, growth, and debt transactions with an investment size of USD 50 – 250 million. The firm makes co-investments and acquires majority and minority interest. | Finance |
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets | Health Technology |
Northstar Neuroscience, Inc.
 Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Health Technology |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Health Technology |
Anchor Therapeutics, Inc.
Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Finance |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Miami University
 Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ohio Dominican University
 Ohio Dominican University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs | Health Technology |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals | Commercial Services |
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
Research Corporation Technologies, Inc.
 Research Corporation Technologies, Inc. Financial ConglomeratesFinance Provides investment related services | Finance |
Neomed Institute
 Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies | Health Technology |
ProMetic Plasma Resources, Inc.
 ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Operates plasma donation centers | Health Services |
